• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Erythrodermic psoriasis after discontinuation of ixekizumab.

作者信息

Potter Kathryn Anne, Motaparthi Kiran, Schoch Jennifer J

机构信息

Department of Dermatology, University of Florida College of Medicine, Gainesville, Florida.

出版信息

JAAD Case Rep. 2017 Dec 18;4(1):22-23. doi: 10.1016/j.jdcr.2017.06.026. eCollection 2018 Jan.

DOI:10.1016/j.jdcr.2017.06.026
PMID:29296644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5739173/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0273/5739173/33a92bcf8f17/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0273/5739173/1109eb8b69aa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0273/5739173/16ddd3f7f087/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0273/5739173/33a92bcf8f17/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0273/5739173/1109eb8b69aa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0273/5739173/16ddd3f7f087/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0273/5739173/33a92bcf8f17/gr3.jpg

相似文献

1
Erythrodermic psoriasis after discontinuation of ixekizumab.停用司库奇尤单抗后发生的红皮病型银屑病。
JAAD Case Rep. 2017 Dec 18;4(1):22-23. doi: 10.1016/j.jdcr.2017.06.026. eCollection 2018 Jan.
2
Long-term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open-label, phase 3 study (UNCOVER-J).依奇珠单抗治疗红皮病型或泛发性脓疱型银屑病日本患者的长期疗效和安全性：一项开放标签、3 期研究（UNCOVER-J）的亚组分析。
J Eur Acad Dermatol Venereol. 2019 Feb;33(2):325-332. doi: 10.1111/jdv.15287. Epub 2018 Nov 15.
3
Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J).司库奇尤单抗治疗日本中重度斑块状银屑病、红皮病型银屑病和泛发性脓疱型银屑病患者的疗效和安全性：一项为期52周的开放标签3期研究（UNCOVER-J）的结果
J Dermatol. 2017 Apr;44(4):355-362. doi: 10.1111/1346-8138.13622. Epub 2016 Oct 11.
4
A case of erythrodermic psoriasis successfully treated with ixekizumab.一例用依奇珠单抗成功治疗的红皮病型银屑病。
Dermatol Ther. 2019 Mar;32(2):e12825. doi: 10.1111/dth.12825. Epub 2019 Jan 31.
5
Erythrodermic psoriasis secondary to systemic corticosteroids.系统性糖皮质激素继发的红皮病型银屑病。
Proc (Bayl Univ Med Cent). 2019 Nov 11;33(1):113-114. doi: 10.1080/08998280.2019.1686911. eCollection 2020 Jan.
6
Erythrodermic Psoriasis Treated with Apremilast.用阿普斯特治疗红皮病型银屑病。
Dermatol Reports. 2016 Sep 19;8(1):6599. doi: 10.4081/dr.2016.6599. eCollection 2016 Jun 15.
7
Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.辅助性 T 细胞 17 型和 22 型在红皮病型银屑病和特应性皮炎中的免疫重叠。
JAMA Dermatol. 2015 Jul;151(7):753-60. doi: 10.1001/jamadermatol.2015.2.
8
Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.依奇珠单抗治疗中重度斑块状银屑病：NICE 单技术评估的循证评估组观点。
Pharmacoeconomics. 2018 Aug;36(8):917-927. doi: 10.1007/s40273-018-0629-2.
9
Exploring the in situ expression of vascular endothelial growth factor and endoglin in pemphigus foliaceus variants and pemphigus vulgaris.探讨寻常型天疱疮和落叶型天疱疮变异型中血管内皮生长因子和内皮下层蛋白的原位表达。
J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1954-1958. doi: 10.1111/jdv.14903. Epub 2018 Apr 6.
10
Long-term efficacy and safety results from an open-label phase III study (UNCOVER-J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab.日本斑块状银屑病患者开放标签 III 期研究（UNCOVER-J）的长期疗效和安全性结果：依奇珠单抗停药和再治疗的影响。
J Eur Acad Dermatol Venereol. 2019 Mar;33(3):568-576. doi: 10.1111/jdv.15292. Epub 2018 Nov 13.

引用本文的文献

1
Update on Erythrodermic Psoriasis: Proposal of a Management Algorithm by an Innovative Severity Evaluation Approach.红皮病型银屑病的最新进展：通过创新的严重程度评估方法提出管理算法建议。
Psoriasis (Auckl). 2025 Jul 19;15:301-320. doi: 10.2147/PTT.S532062. eCollection 2025.
2
Biologics for the Management of Erythrodermic Psoriasis: An Updated Review.用于红皮病型银屑病治疗的生物制剂：最新综述
Clin Cosmet Investig Dermatol. 2023 Aug 4;16:2045-2059. doi: 10.2147/CCID.S407813. eCollection 2023.
3
Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances.

本文引用的文献

1
Ixekizumab: A Review in Moderate to Severe Plaque Psoriasis.司库奇尤单抗：中重度斑块状银屑病的综述
Am J Clin Dermatol. 2017 Feb;18(1):147-158. doi: 10.1007/s40257-017-0254-4.
2
Erythroderma. A clinical and etiological study of 103 patients.红皮病。103例患者的临床与病因学研究。
J Dermatol Case Rep. 2016 Mar 31;10(1):1-9. doi: 10.3315/jdcr.2016.1222.
3
Erythroderma in two patients with psoriasis upon discontinuation of efalizumab treatment.两名银屑病患者停用依法利珠单抗治疗后出现红皮病。
靶向治疗红皮病型银屑病：原理与最新进展。
Drugs. 2020 Apr;80(6):525-534. doi: 10.1007/s40265-020-01283-2.
4
Erythrodermic Psoriasis Causing Uric Acid Crystal Nephropathy.红皮病型银屑病导致尿酸结晶肾病。
Case Rep Med. 2019 Mar 28;2019:8165808. doi: 10.1155/2019/8165808. eCollection 2019.
5
Dilated Blood and Lymphatic Microvessels, Angiogenesis, Increased Macrophages, and Adipocyte Hypertrophy in Lipedema Thigh Skin and Fat Tissue.脂性水肿大腿皮肤和脂肪组织中扩张的血液和淋巴管微血管、血管生成、巨噬细胞增多以及脂肪细胞肥大。
J Obes. 2019 Mar 3;2019:8747461. doi: 10.1155/2019/8747461. eCollection 2019.
J Dermatolog Treat. 2009;20(1):67-9. doi: 10.1080/09546630802206694.
4
Generalized pustular psoriasis following withdrawal of efalizumab.依法珠单抗撤药后泛发性脓疱型银屑病
J Drugs Dermatol. 2004 Jan-Feb;3(1):77-9.